Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
Aims: To assess the comparative effects of glucagon-like peptide-1 receptor agonists (GLP-1RA), 4-dipeptidyl peptidase inhibitors (DPP-4I), and metformin treatment during one year on metabolic syndrome (MetS) components and severity in MetS patients. Methods: Prospective study (n = 6165 adults) with...
Similar Items
-
Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis.
by: Nuria Rosique-Esteban, et al.
Published: (2017-01-01) -
Análisis espacial y diacrónico del paisaje histórico del yacimiento arqueológico de Begastri mediante SIG
by: Miguel Martínez Sánchez, et al.
Published: (2019-09-01) -
El uso de la fotogrametría en la ciudad visigoda de Begastri: caso de estudio
by: José Javier Martínez García, et al.
Published: (2021-08-01) -
Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk.
by: Marta Guasch-Ferré, et al.
Published: (2012-01-01) -
Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis
by: Víctor Micó, et al.
Published: (2022-09-01)